title: Second primary malignancies in chronic myeloid leukemia patients.
authors.forename: Tugce
authors.initials: T
authors.lastname: Caliskan
authors.affiliation: Department of Internal Medicine; Division of Hematology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
authors.forename: Ahmet Emre
authors.initials: AE
authors.lastname: Eskazan
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications* / Q000209:etiology*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate